Eli Lilly and Company (NYSE:LLY) Trading Down 4.6% After Analyst Downgrade
Eli Lilly and Company (NYSE:LLY – Get Free Report) shares dropped 4.6% on Thursday after Morgan Stanley lowered their price target on the stock from $1,146.00 to $1,124.00. Morgan Stanley currently has an overweight rating on the stock. Eli Lilly and Company traded as low as $718.81 and last traded at $718.89. Approximately 663,002 shares […]
